Barclays’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-174,042
Closed -$1.6M 4235
2021
Q2
$1.6M Buy
174,042
+142,896
+459% +$1.31M ﹤0.01% 1854
2021
Q1
$155K Buy
31,146
+19,119
+159% +$95.1K ﹤0.01% 3221
2020
Q4
$52K Sell
12,027
-5,182
-30% -$22.4K ﹤0.01% 3165
2020
Q3
$74K Sell
17,209
-3,217
-16% -$13.8K ﹤0.01% 3138
2020
Q2
$93K Buy
20,426
+8,145
+66% +$37.1K ﹤0.01% 3157
2020
Q1
$49K Sell
12,281
-24,769
-67% -$98.8K ﹤0.01% 3113
2019
Q4
$314K Buy
37,050
+18,538
+100% +$157K ﹤0.01% 2949
2019
Q3
$127K Sell
18,512
-5,369
-22% -$36.8K ﹤0.01% 3281
2019
Q2
$199K Buy
23,881
+11,426
+92% +$95.2K ﹤0.01% 3203
2019
Q1
$114K Buy
12,455
+12,057
+3,029% +$110K ﹤0.01% 3282
2018
Q4
$4K Sell
398
-11,982
-97% -$120K ﹤0.01% 3814
2018
Q3
$173K Buy
12,380
+8,982
+264% +$126K ﹤0.01% 3147
2018
Q2
$36K Sell
3,398
-1,879
-36% -$19.9K ﹤0.01% 3421
2018
Q1
$45K Buy
5,277
+1,287
+32% +$11K ﹤0.01% 3549
2017
Q4
$38K Buy
3,990
+3,406
+583% +$32.4K ﹤0.01% 3454
2017
Q3
$5K Sell
584
-2,228
-79% -$19.1K ﹤0.01% 3676
2017
Q2
$24K Sell
2,812
-11,808
-81% -$101K ﹤0.01% 3224
2017
Q1
$103K Buy
+14,620
New +$103K ﹤0.01% 2822
2015
Q2
Sell
-316
Closed -$2K 4263
2015
Q1
$2K Sell
316
-536
-63% -$3.39K ﹤0.01% 3933
2014
Q4
$6K Sell
852
-9,814
-92% -$69.1K ﹤0.01% 3910
2014
Q3
$96K Buy
10,666
+10,258
+2,514% +$92.3K ﹤0.01% 2667
2014
Q2
$7K Buy
408
+173
+74% +$2.97K ﹤0.01% 3810
2014
Q1
$4K Buy
+235
New +$4K ﹤0.01% 4063